WuXi Biologics (Suzhou) Successfully Passed First EMA GMP Inspection |
| April 14, 2020 | April 2020 Bond Updates |
|
SUZHOU, China, April 13, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platform, announced that WuXi Biologics (Suzhou) Co., Ltd. has successfully passed its first GMP inspection by the European Medicines Agency... |
| View more at: https://www.prnewswire.com:443/news-releases/wuxi-biologics-suzhou-successfully-passed-first-ema-gmp-inspection-301039728.html |
| Related News |